Endo, Arnold & Porter Split Amid Opioid Litigation Troubles
Amid a major controversy over discovery shortcomings, Endo Pharmaceuticals disclosed late Friday that Arnold & Porter is departing as its counsel in multidistrict opioid litigation and being replaced by Skadden....To view the full article, register now.
Already a subscriber? Click here to view full article